Sphera Funds Management Ltd. Blueprint Medicines Corp Transaction History

Sphera Funds Management Ltd.

  • $545 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020
SELL
$57.09 - $79.27 $6.25 Million - $8.68 Million
-109,500 Closed
0 $0
Q1 2020

May 14, 2020
BUY
$48.11 - $82.22 $168,385 - $287,770
3,500 Added 3.3%
109,500 $6.4 Million
Q4 2019

Feb 13, 2020
BUY
$66.73 - $82.59 $4.24 Million - $5.24 Million
63,500 Added 149.41%
106,000 $8.49 Million
Q3 2019

Nov 14, 2019
BUY
$72.9 - $101.41 $3.1 Million - $4.31 Million
42,500 New
42,500 $3.12 Million

Others Institutions Holding BPMC

# of Institutions
351
Shares Held
60.3M
Call Options Held
2.25M
Put Options Held
1.18M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.4B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email